Novo Nordisk CEO Says Wegovy Pill Captures 80% of New Oral Starts
Novo Nordisk’s CEO said the Wegovy pill is still capturing around 80% of new oral patient starts.
Novo Nordisk’s CEO said the Wegovy pill is still capturing around 80% of new oral patient starts.